CARGO Therapeutics, Inc. (CRGX)
(Delayed Data from NSDQ)
$14.89 USD
+0.23 (1.57%)
Updated Dec 26, 2024 03:59 PM ET
After-Market: $14.91 +0.02 (0.13%) 7:58 PM ET
2-Buy of 5 2
D Value C Growth F Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
CRGX 14.89 +0.23(1.57%)
Will CRGX be a Portfolio Killer in December?
Zacks Investment Research is releasing its prediction for CRGX based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for CRGX
Down -14.13% in 4 Weeks, Here's Why CARGO Therapeutics, Inc. (CRGX) Looks Ripe for a Turnaround
Bears are Losing Control Over CARGO Therapeutics, Inc. (CRGX), Here's Why It's a 'Buy' Now
CRGX: What are Zacks experts saying now?
Zacks Private Portfolio Services
What Makes CARGO Therapeutics, Inc. (CRGX) a New Buy Stock
Wall Street Analysts See a 56.26% Upside in CARGO Therapeutics, Inc. (CRGX): Can the Stock Really Move This High?
Company News for Mar 25, 2024
Other News for CRGX
Piper Sandler Reaffirms Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)
CARGO Therapeutics, Inc. (CRGX) Receives a Buy from Truist Financial
CARGO Therapeutics, Inc.: Buy Rating Backed by Promising CAR-T Developments and Positive Clinical Data
CARGO Therapeutics files automatic mixed securities shelf
Cargo Therapeutics files automatic mixed securities shelf